Search Results 241-250 of 16373 for monoclonal antibody

1. Asher A. Chanan-Khan, M.D. - Mayo Clinic Faculty Profiles

   Monoclonal antibody therapies in multiple myeloma. Preclinical models of Waldenstrom macroglobulinemia. Significance to Patient Care. Dr. Chanan-Khan is ...

2. Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery - Mayo Clinic

   Cryosurgery, also known as cryoablation or cryotherapy, kills tumor cells by freezing them. Monoclonal antibodies, such as pembrolizumab, may block tumor growth ...

3. A Study of Pembrolizumab and Ruxolitinib Phosphate for Treating Patients with Metastatic Stage IV Triple Negative Breast Cancer - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Has had a prior anti-cancer monoclonal antibody (mAb) ≤4 weeks prior to ...

4. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find ...

5. Coronavirus disease 2019 (COVID-19) - Symptoms and causes - Mayo Clinic

   The FDA has also authorized the monoclonal antibody pemivibart (Pemgarda) to prevent COVID-19 in some people with weakened immune systems. Control the ...

6. A Study to Test Sacituzumab Govitecan Therapy in Patients with HER2-Negative Breast Cancer and Brain Metastases - Mayo Clinic

   Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted ...

7. Vinorelbine Tartrate and Cyclophosphamide in Combination with Bevacizumab or Temsirolimus in Treating Patients with Recurrent or Refractory Rhabdomyosarcoma - Mayo Clinic

   Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. ... 3 half-lives (or 6 weeks) must have elapsed since previous monoclonal ...

8. Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

9. Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis - Mayo Clinic

   Monoclonal antibodies, such as isatuximab, may ... Patients must not have any known allergies to isatuximab or other monoclonal antibody therapies.

10. A Study to Evaluate Regorafenib with Cetuximab or Panitumumab to Treat Unresectable, Locally Advanced, or Metastatic Colorectal Cancer - Mayo Clinic

    Regorafenib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as cetuximab or panitumumab, ...